02607 SH PHARMA
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 1.36X | Oper Margin | 3.4% |
|---|---|---|---|
| LT Debt/Equity | 13.6% | Net Margin | 1.7% |
| Total Debt/Equity | 66.7% | Return on Equity | 6.4% |
| Price/Book | 0.59X | Return on Assets | 2.1% |
| (HKD 12.190) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | 4,841.61 | 4,153.09 | 6,297.95 | 6,229.82 | 5,336.11 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +16.6 | -34.1 | +1.1 | +16.8 | +17.0 |
| Earnings Per Share (HKD) | 1.307 | 1.122 | 1.808 | 2.192 | 1.878 |
| Earnings Per Share Growth (%) | +16.5 | -38.0 | -17.5 | +16.8 | +17.0 |
| Dividend Per Share (HKD) | 0.404 | 0.441 | 0.664 | 0.492 | 0.576 |
| P/E* (X) | 9.33 | 10.86 | 6.74 | 5.56 | 6.49 |
| Yield (%) | 3.32 | 3.62 | 5.45 | 4.04 | 4.73 |
| Dividend Share (%) | 30.93 | 39.27 | 36.71 | 22.45 | 30.69 |
| Book NAV (HKD) | 20.558 | 20.395 | 20.335 | 21.242 | 18.939 |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-09-08 21:40:20
Latest Result
| (RMBMn) | 2025-06 | 2024-06 | Chg* (%) | 2023-06 |
| Cover Period (mths) | 6 | 6 | NA | 6 |
|---|---|---|---|---|
| Turnover | 141,593 | 139,413 | +1.6 | 132,592 |
| Operating Result | 6,413 | 4,326 | +48.2 | 4,550 |
| Associates | 380.664 | 365.613 | +4.1 | -65.419 |
| Profit Before Taxation | 6,821 | 4,822 | +41.5 | 4,534 |
| Taxation | 1,826 | 1,225 | +49.1 | 1,117 |
| Profit /( Loss) After Taxation | 4,995 | 3,597 | +38.9 | 3,417 |
| Minority Interests | 535.919 | 655.452 | -18.2 | 807.179 |
| Net Profit | 4,459 | 2,942 | +51.6 | 2,610 |
| Earnings Per Share () | 1.3175 | 0.8537 | +54.3 | 0.7614 |
| Dividend Per Share () | 0.0000 | 0.0874 | -100.0 | 0.0000 |
| Announcement Date | 2025-08-28 | 2024-08-26 | NA | 2023-08-29 |
* Annualised
Last Update Time: 2025-09-08 21:40:25
